Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

DONALD A BARONE

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1396933768
CMS profile
289896
Location
CAMDEN, NJ

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2019 · Entire year

$52,402.36

59 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2019 · entire year · sorted by reported total

By paying entity

PY2019 · entire year · sorted by reported total

Paying entityAmountRecords
GENZYME CORPORATION $36,605.30 38
Genentech USA, Inc. $9,383.33 10
EMD Serono, Inc. $4,750.46 6
Alexion Pharmaceuticals, Inc. $1,458.84 3
Biogen, Inc. $107.44 1
Celgene Corporation $96.99 1

Page 1 of 2; records 1–50 of 59 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

DONALD A BARONE

NPI 1396933768 · CMS profile ID 289896

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Neurology

CAMDEN, NJ

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 2; records 1–50 of 59 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1396933768?year=2019&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
DONALD A BARONE, NPI 1396933768, CMS profile ID 289896. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 2; records 1–50 of 59 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1396933768?year=2019&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
APA 7
IndustryPayments. (2026). DONALD A BARONE, NPI 1396933768, CMS profile ID 289896. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 2; records 1–50 of 59 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1396933768?year=2019&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
Bluebook
DONALD A BARONE, NPI 1396933768, CMS profile ID 289896, IndustryPayments, General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 2; records 1–50 of 59 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e. https://industrypayments.org/provider/npi-1396933768?year=2019&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2019 · Physicians and non-physician practitioners · CMS publication 2026-06-30

59 matching records · $52,402.36 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 59 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 59.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
EMD Serono, Inc. $2,150.0012/19/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 702947985 CMS
Celgene Corporation $96.9911/25/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 672972301 CMS
Biogen, Inc. $107.4411/06/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 660615519 CMS
EMD Serono, Inc. $2.6610/30/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 703021921 CMS
GENZYME CORPORATION $55.0810/29/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694257719 CMS
GENZYME CORPORATION $3,675.0010/29/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694257721 CMS
GENZYME CORPORATION $507.6310/29/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694326963 CMS
GENZYME CORPORATION $13.8810/23/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694228729 CMS
GENZYME CORPORATION $2,573.0010/23/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694228733 CMS
GENZYME CORPORATION $22.3010/23/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694234175 CMS
GENZYME CORPORATION $2,573.0010/23/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694234177 CMS
GENZYME CORPORATION $56.5410/15/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694172115 CMS
GENZYME CORPORATION $10.6010/10/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694174365 CMS
GENZYME CORPORATION $3,675.0010/02/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694222239 CMS
GENZYME CORPORATION $13.4910/02/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694321521 CMS
GENZYME CORPORATION $70.0710/01/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694201477 CMS
GENZYME CORPORATION $52.6309/11/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694126893 CMS
GENZYME CORPORATION $7.0809/04/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694172595 CMS
GENZYME CORPORATION $4,410.0009/04/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694172597 CMS
GENZYME CORPORATION $52.8109/04/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694172599 CMS
GENZYME CORPORATION $54.4109/04/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694173107 CMS
GENZYME CORPORATION $21.7909/04/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694173129 CMS
GENZYME CORPORATION $2,573.0009/04/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694173133 CMS
GENZYME CORPORATION $45.8109/04/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694173135 CMS
GENZYME CORPORATION $47.4109/04/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694173137 CMS
GENZYME CORPORATION $102.0009/04/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694173139 CMS
GENZYME CORPORATION $2,573.0009/04/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694173645 CMS
GENZYME CORPORATION $45.8109/04/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694173647 CMS
GENZYME CORPORATION $47.4209/04/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694312331 CMS
Alexion Pharmaceuticals, Inc. $125.0008/20/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695485419 CMS
EMD Serono, Inc. $2,150.0008/20/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 702947469 CMS
Genentech USA, Inc. $491.3108/06/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681331223 CMS
Genentech USA, Inc. $2,525.0008/06/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 857128719 CMS
GENZYME CORPORATION $109.3008/01/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694129405 CMS
GENZYME CORPORATION $2,818.0008/01/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694298935 CMS
GENZYME CORPORATION $119.7407/18/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694112967 CMS
GENZYME CORPORATION $2,818.0007/18/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694286707 CMS
Alexion Pharmaceuticals, Inc. $1,320.0007/17/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695485765 CMS
EMD Serono, Inc. $80.1907/16/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 702957055 CMS
Genentech USA, Inc. $324.4006/08/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681340769 CMS
Genentech USA, Inc. $564.6006/08/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681368691 CMS
Genentech USA, Inc. $265.0706/08/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681387367 CMS
Genentech USA, Inc. $63.6006/08/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681392955 CMS
Genentech USA, Inc. $25.0006/08/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681406055 CMS
Genentech USA, Inc. $2,450.0006/08/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 857128717 CMS
Alexion Pharmaceuticals, Inc. $13.8406/06/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695485362 CMS
GENZYME CORPORATION $41.7406/05/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694094893 CMS
GENZYME CORPORATION $2,573.0006/05/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694094895 CMS
Genentech USA, Inc. $2,525.0005/23/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 857128713 CMS
EMD Serono, Inc. $5.8805/15/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 703015223 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $52,402.36 59
PY2020 $25,426.68 51
PY2021 $20,653.37 29
PY2022 $36,543.66 66
PY2023 $44,993.61 56
PY2024 $36,629.29 77
PY2025 $18,644.71 45

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2021 Recipient $970.00 3
PY2020 Recipient $443.33 2
PY2020 Principal investigator $1,344.00 1
PY2019 Recipient $1,634.06 10
PY2019 Principal investigator $30.74 1

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

3 records in PY2020

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Recipient GENZYME CORPORATION $130.00 09/11/2020 Covered Recipient Physician Comparison of Alemtuzumab and Rebif Efficacy in Multiple Sclerosis, Study Two (CARE-MS II): A Phase 3, Randomized, Rater- and Dose-Blinded Study Comparing Two Annual Cycles of Intravenous Low- and Hig No dispute reported 06/30/2026 744025115
Recipient GENZYME CORPORATION $313.33 09/11/2020 Covered Recipient Physician Comparison of Alemtuzumab and Rebif Efficacy in Multiple Sclerosis, Study Two (CARE-MS II): A Phase 3, Randomized, Rater- and Dose-Blinded Study Comparing Two Annual Cycles of Intravenous Low- and Hig No dispute reported 06/30/2026 744025125
Principal investigator 1 EMD Serono, Inc. $1,344.00 06/25/2020 Non-covered Recipient Entity
DONALD A BARONE DO LLC
Evaluating the Long-Term Outcomes and Durability of Effect following treatment with Cladribine Tablets for Multiple Sclerosis: An Exploratory Phase IV ambispective study of patients who previously participated in the CLARITY/CLARITY-EXT and ORACLE Trials No dispute reported 06/30/2026 749606732